Livzon Pharma Jumps Over 10% in Morning Session on Generous Dividend Payout and Three-Year Shareholder Return Plan

Deep News10-26 10:30

Livzon Pharma (01513) surged more than 10% in morning trading, with shares up 10.63% as of press time to HK$22.90, on turnover of HK$71.81 million.

The company announced a plan to distribute a cash dividend of RMB 12.39 per 10 shares (tax inclusive) to all shareholders, with total cash dividends expected to reach RMB 1.10 billion.

Notably, the company has also formulated a "Three-Year (2026–2028) Shareholder Return Plan," which specifies that, provided conditions for cash dividends are met, the total annual cash dividend payout shall in principle be no less than 90% of the distributable profit realized in that year, and the aggregate annual cash dividend amount shall in principle be no less than RMB 2 billion (tax inclusive).

Livzon Pharma's third-quarter report shows that for the first three quarters of 2026, operating revenue was RMB 7.319 billion, down 19.71% year-on-year; net profit attributable to shareholders of the listed company was RMB 1.288 billion, down 26.57% year-on-year. For the third quarter alone, main operating revenue was RMB 2.32 billion, down 18.44% year-on-year; net profit attributable to shareholders for the quarter was RMB 356 million, down 24.76% year-on-year.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1132150019?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-10-26 10:30","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1132150019","market":"nz","top_or_hot":-1,"title":"Livzon Pharma Jumps Over 10% in Morning Session on Generous Dividend Payout and Three-Year Shareholder Return Plan","media":"Deep News","content":"<p>Livzon Pharma (<b>01513</b>) surged more than 10% in morning trading, with shares up 10.63% as of press time to HK$22.90, on turnover of HK$71.81 million.<br><br>The company announced a plan to distribute a cash dividend of RMB 12.39 per 10 shares (tax inclusive) to all shareholders, with total cash dividends expected to reach RMB 1.10 billion.<br><br>Notably, the company has also formulated a \"Three-Year (2026–2028) Shareholder Return Plan,\" which specifies that, provided conditions for cash dividends are met, the total annual cash dividend payout shall in principle be no less than 90% of the distributable profit realized in that year, and the aggregate annual cash dividend amount shall in principle be no less than RMB 2 billion (tax inclusive).<br><br>Livzon Pharma's third-quarter report shows that for the first three quarters of 2026, operating revenue was RMB 7.319 billion, down 19.71% year-on-year; net profit attributable to shareholders of the listed company was RMB 1.288 billion, down 26.57% year-on-year. For the third quarter alone, main operating revenue was RMB 2.32 billion, down 18.44% year-on-year; net profit attributable to shareholders for the quarter was RMB 356 million, down 24.76% year-on-year.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Livzon Pharma Jumps Over 10% in Morning Session on Generous Dividend Payout and Three-Year Shareholder Return Plan</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLivzon Pharma Jumps Over 10% in Morning Session on Generous Dividend Payout and Three-Year Shareholder Return Plan\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1039043262\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Deep News </p>\n<p class=\"h-time\">2026-10-26 10:30</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Livzon Pharma (<b>01513</b>) surged more than 10% in morning trading, with shares up 10.63% as of press time to HK$22.90, on turnover of HK$71.81 million.<br><br>The company announced a plan to distribute a cash dividend of RMB 12.39 per 10 shares (tax inclusive) to all shareholders, with total cash dividends expected to reach RMB 1.10 billion.<br><br>Notably, the company has also formulated a \"Three-Year (2026–2028) Shareholder Return Plan,\" which specifies that, provided conditions for cash dividends are met, the total annual cash dividend payout shall in principle be no less than 90% of the distributable profit realized in that year, and the aggregate annual cash dividend amount shall in principle be no less than RMB 2 billion (tax inclusive).<br><br>Livzon Pharma's third-quarter report shows that for the first three quarters of 2026, operating revenue was RMB 7.319 billion, down 19.71% year-on-year; net profit attributable to shareholders of the listed company was RMB 1.288 billion, down 26.57% year-on-year. For the third quarter alone, main operating revenue was RMB 2.32 billion, down 18.44% year-on-year; net profit attributable to shareholders for the quarter was RMB 356 million, down 24.76% year-on-year.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IDVY","symbol_name":"First Trust International Rising Dividend Achievers ETF","start_time":0,"source_url":"","article_id":"1132150019","we_media_id":"1039043262","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1132150019","pubTimestamp":1792981831,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Deep News","introduction":"Global Stock Market Deep Analysis","home_visible":1,"id":"1039043262","head_image":"https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922"},"summary":"Livzon Pharma (01513) surged more than 10% in morning trading, with shares up 10.63% as of press time to HK$22.90, on turnover of HK$71.81 million.The company announced a plan to distribute a cash...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"IDVY":"First Trust International Rising Dividend Achievers ETF","LCOW":"Pacer S&P 500 Quality FCF Aristocrats ETF","IPKW":"Invesco International BuyBack Achievers ETF","SHRY":"First Trust Bloomberg Shareholder Yield ETF","VIG":"股利增长指数ETF-Vanguard","STXD":"STRIVE 1000 DIVIDEND GROWTH ETF","01513":"丽珠医药","COWZ":"Pacer US Cash Cows 100 ETF","LGCF":"THEMES US CASH FLOW CHAMPIONS ETF","PKW":"Invesco BuyBack Achievers ETF","SYLD":"股东总收益美股ETF-Cambria","BK1191":"制药","DIVG":"INVESCO S&P 500 HIGH DIVIDEND GROWERS ETF","BK4588":"碎股","MYLD":"Cambria Micro and Small Cap Shareholder Yield ETF","BK4585":"ETF&股票定投概念","LYLD":"Cambria Large Cap Shareholder Yield ETF","TPFC":"Timothy Plan Free Cash Flow ETF"},"translate_title":"丽珠医药因丰厚股息支付和三年股东回报计划早盘上涨超过10%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"VIG":1,"LYLD":1,"STXD":1,"IDVY":1,"01513":1,"COWZ":1,"DIVG":1,"LGCF":1,"IPKW":1,"SHRY":1,"MYLD":1,"TPFC":1,"PKW":1,"SYLD":1,"LCOW":1},"content_text":"Livzon Pharma (01513) surged more than 10% in morning trading, with shares up 10.63% as of press time to HK$22.90, on turnover of HK$71.81 million.The company announced a plan to distribute a cash dividend of RMB 12.39 per 10 shares (tax inclusive) to all shareholders, with total cash dividends expected to reach RMB 1.10 billion.Notably, the company has also formulated a \"Three-Year (2026–2028) Shareholder Return Plan,\" which specifies that, provided conditions for cash dividends are met, the total annual cash dividend payout shall in principle be no less than 90% of the distributable profit realized in that year, and the aggregate annual cash dividend amount shall in principle be no less than RMB 2 billion (tax inclusive).Livzon Pharma's third-quarter report shows that for the first three quarters of 2026, operating revenue was RMB 7.319 billion, down 19.71% year-on-year; net profit attributable to shareholders of the listed company was RMB 1.288 billion, down 26.57% year-on-year. For the third quarter alone, main operating revenue was RMB 2.32 billion, down 18.44% year-on-year; net profit attributable to shareholders for the quarter was RMB 356 million, down 24.76% year-on-year.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1132150019","isCrawlerRequest":true}